Zebrafish Disease Model lab, Biomedical Research Foundation Academy of Athens, Athens 115 27, Greece.
Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University of Athens, Athens 176 71, Greece.
Biol Open. 2021 Mar 9;10(3):bio058542. doi: 10.1242/bio.058542.
Protein kinase D2 belongs to a family of evolutionarily conserved enzymes regulating several biological processes. In a forward genetic screen for zebrafish cardiovascular mutants, we identified a mutation in the gene. Homozygous mutant embryos develop as wild type up to 36 h post-fertilization and initiate blood flow, but fail to maintain it, resulting in a complete outflow tract stenosis. We identified a mutation in the gene that results in a T757A substitution at a conserved residue in the kinase domain activation loop (T714A in human PRKD2) that disrupts catalytic activity and drives this phenotype. Homozygous mutants survive without circulation for several days, allowing us to study the extreme phenotype of no intracardiac flow, in the background of a functional heart. We show dysregulation of atrioventricular and outflow tract markers in the mutants and higher sensitivity to the Calcineurin inhibitor, Cyclosporin A. Finally we identify TBX5 as a potential regulator of PRKD2. Our results implicate PRKD2 catalytic activity in outflow tract development in zebrafish.This article has an associated First Person interview with the first author of the paper.
蛋白激酶 D2 属于一类进化上保守的酶,调节着多种生物学过程。在斑马鱼心血管突变体的正向遗传筛选中,我们鉴定了 基因中的一个突变。纯合突变胚胎在受精后 36 小时内发育为野生型,并启动血流,但不能维持血流,导致完全流出道狭窄。我们鉴定了 基因中的一个突变,导致激酶结构域激活环中一个保守残基的 T757A 取代(人 PRKD2 中的 T714A),破坏了催化活性,并导致这种表型。纯合突变体在没有循环的情况下存活数天,使我们能够在心脏功能正常的背景下研究无心脏内血流的极端表型。我们显示突变体中房室和流出道标记物的失调,以及对钙调神经磷酸酶抑制剂环孢素 A 的更高敏感性。最后,我们确定 TBX5 是 PRKD2 的一个潜在调节因子。我们的结果表明,PRKD2 的催化活性参与了斑马鱼流出道的发育。本文有一篇与该论文第一作者相关的第一人称采访。